NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia

NCT06021197 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: NMDAE
DRUG: Placebo Cap

Sponsor

China Medical University Hospital

Collaborators

[object Object]